Cite
Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects.
MLA
Pang, Jia-Hui, et al. “Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects.” Vaccines, vol. 12, no. 1, Jan. 2024, p. 56. EBSCOhost, https://doi.org/10.3390/vaccines12010056.
APA
Pang, J.-H., Guo, C.-F., Hao, P.-L., Meng, S.-L., Guo, J., Zhang, D., Ji, Y.-Q., & Ming, P.-G. (2024). Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects. Vaccines, 12(1), 56. https://doi.org/10.3390/vaccines12010056
Chicago
Pang, Jia-Hui, Chang-Fu Guo, Peng-Liang Hao, Sheng-Li Meng, Jing Guo, Dou Zhang, Ya-Qi Ji, and Ping-Gang Ming. 2024. “Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects.” Vaccines 12 (1): 56. doi:10.3390/vaccines12010056.